Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Saxagliptin Market: By Dosage: 2.5 mg, 5 mg, Others; By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments

Global Saxagliptin Market Outlook

The global saxagliptin market is expected to grow at a CAGR of 4% in the forecast period of 2023-2028.

 

Saxagliptin Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The Asia Pacific Region to Witness a Robust Growth in the Saxagliptin Industry, Owing to Rising Government Funding

The market for saxagliptin is being driven by the rising cases of diabetes across the globe. North America and Europe are the significant markets for saxagliptin globally. This is attributed to a large number of ageing population and the rising prevalence of type II diabetes. The Asia Pacific region is expected to witness a robust growth rate in the forecast period. Countries, especially China and India, are predicted to exhibit a high growth rate of the saxagliptin industry in the Asia Pacific region. Factors such as increasing healthcare expenditure, a large pool of patients, and rising government funding are contributing to the market growth of saxagliptin in the Asia Pacific.

 

Saxagliptin Market by dosage

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Saxagliptin: Market Segmentation

Saxagliptin is the medicine used to treat diabetes. It works by boosting the level of insulin in the body produced after the meal. The product is marketed under the brand name called Onglyza. Saxagliptin acts on a natural hormone in the body, which is called incretins. The product has various side effects such as urinary tract infection, headache, upper respiratory tract infection, and nasopharyngitis. Saxagliptin can also cause complications like stroke and heart attack.

On the basis of dosage, the market is divided into:

  • 2.5 mg
  • 5 mg
  • Others

Based on distribution channel, the industry can be segmented into:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Saxagliptin Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Incidences of Type II Diabetes to Aid the Global Market Growth of Saxagliptin

The market for saxagliptin is being driven by the rising incidences of type II diabetes across the globe. The market drivers, such as increased sedentary lifestyle, rising prevalence of obesity, increased government funding, and junk food habits, are contributing to the market growth of saxagliptin. Further, the rising healthcare awareness is expected to fuel the market growth over the forecast period. The market is expanding due to further innovations taking place in the saxagliptin industry. This is further expected to aid the market growth over the forecast period. However, the market is expected to witness a setback owing to the factors, such as stringent regulations for the approval of drugs and the availability of substitutes for the treatment of diabetes.

 

Key Industry Players in the Global Saxagliptin Market

The report gives a detailed analysis of the following key players in the global saxagliptin market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • AstraZeneca plc.
  • Wellona Pharma
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Dosage, Distribution Channel, Region
Breakup by Dosage 2.5 mg, 5 mg, Others
Breakup by Distribution Channel Hospital Pharmacy, Retail Pharmacy, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered AstraZeneca plc., Wellona Pharma, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Saxagliptin Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Saxagliptin Historical Market (2018-2022) 
    8.3    Global Saxagliptin Market Forecast (2023-2028)
    8.4    Global Saxagliptin Market by Dosage
        8.4.1    2.5 mg
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    5 mg
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Others
    8.5    Global Saxagliptin Market by Distribution Channel
        8.5.1    Hospital Pharmacy
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Retail Pharmacy
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Others    
    8.6    Global Saxagliptin Market by Region
        8.6.1    North America
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021) 
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Europe
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021) 
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Asia Pacific
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021) 
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Latin America
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021) 
            8.6.4.3    Forecast Trend (2022-2027)
        8.6.5    Middle East and Africa
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2017-2021) 
            8.6.5.3    Forecast Trend (2022-2027)
9    North America Saxagliptin Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2017-2021) 
        9.1.3    Forecast Trend (2022-2027)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2017-2021) 
        9.2.3    Forecast Trend (2022-2027)
10    Europe Saxagliptin Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2017-2021) 
        10.1.3    Forecast Trend (2022-2027)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2017-2021) 
        10.2.3    Forecast Trend (2022-2027)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2017-2021) 
        10.3.3    Forecast Trend (2022-2027)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2017-2021) 
        10.4.3    Forecast Trend (2022-2027)
    10.5    Others
11    Asia Pacific Saxagliptin Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2017-2021) 
        11.1.3    Forecast Trend (2022-2027)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2017-2021) 
        11.2.3    Forecast Trend (2022-2027)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2017-2021) 
        11.3.3    Forecast Trend (2022-2027)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2017-2021) 
        11.4.3    Forecast Trend (2022-2027)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2017-2021) 
        11.5.3    Forecast Trend (2022-2027)
    11.6    Others
12    Latin America Saxagliptin Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2017-2021) 
        12.1.3    Forecast Trend (2022-2027)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2017-2021) 
        12.2.3    Forecast Trend (2022-2027)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2017-2021) 
        12.3.3    Forecast Trend (2022-2027)
    12.4    Others
13    Middle East and Africa Saxagliptin Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2017-2021) 
        13.1.3    Forecast Trend (2022-2027)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2017-2021) 
        13.2.3    Forecast Trend (2022-2027)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2017-2021) 
        13.3.3    Forecast Trend (2022-2027)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2017-2021) 
        13.4.3    Forecast Trend (2022-2027)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    AstraZeneca plc.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Wellona Pharma
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Others
17    Key Trends and Developments in the Market


    
List of Key Figures and Tables

1.    Global Saxagliptin Market: Key Industry Highlights, 2018 and 2028
2.    Global Saxagliptin Historical Market: Breakup by Dosage (USD Million), 2018-2022
3.    Global Saxagliptin Market Forecast: Breakup by Dosage (USD Million), 2023-2028
4.    Global Saxagliptin Historical Market: Breakup by Distribution Channel (USD Million), 2018-2022
5.    Global Saxagliptin Market Forecast: Breakup by Distribution Channel (USD Million), 2023-2028
6.    Global Saxagliptin Historical Market: Breakup by Region (USD Million), 2018-2022
7.    Global Saxagliptin Market Forecast: Breakup by Region (USD Million), 2023-2028
8.    North America Saxagliptin Historical Market: Breakup by Country (USD Million), 2018-2022
9.    North America Saxagliptin Market Forecast: Breakup by Country (USD Million), 2023-2028
10.    Europe Saxagliptin Historical Market: Breakup by Country (USD Million), 2018-2022
11.    Europe Saxagliptin Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Asia Pacific Saxagliptin Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Asia Pacific Saxagliptin Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Latin America Saxagliptin Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Latin America Saxagliptin Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Middle East and Africa Saxagliptin Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Middle East and Africa Saxagliptin Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Global Saxagliptin Market Structure

Key Questions Answered in the Report

The global saxagliptin market is projected to grow at a CAGR of 4% between 2021 and 2026.

The major drivers of the industry, such as rising disposable incomes, increasing population, rising prevalence of diabetes, a growing number of ageing population, rising healthcare expenditure, large pool of patients, increasingly sedentary lifestyle, and growing prevalence of obesity, are expected to aid the market growth.

The key trends guiding the growth of the market include the rising innovations and increasing government funding.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading dosages of saxagliptin in the market are 2.5 mg and 5 mg, among others.

The major distribution channels in the industry are hospital pharmacy and retail pharmacy, among others.

The major players in the industry are AstraZeneca plc. and Wellona Pharma, among others.

Analyst Review

The global saxagliptin market is being driven by the rising prevalence of diabetes. Aided by the rising innovations in the industry, the market is expected to witness a moderate growth in the forecast period of 2023-2028, growing at a CAGR of 4%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on dosage, the market is segmented into 2.5 mg and 5 mg, among others. On the basis of distribution channel, the industry is divided into hospital pharmacy and retail pharmacy, among others. The major regional markets for saxagliptin are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AstraZeneca plc. and Wellona Pharma, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER